Clinical predictors of remission and low disease activity in Latin American early rheumatoid arthritis: data from the GLADAR cohort (vol 38, pg 2737, 2019)

被引：0

作者：

Gamboa-Cardenas, Rocio V. ^{[1
]}

Ugarte-Gil, Manuel F. ^{[1
,2
]}

Massardo, Loreto ^{[3
]}

Sacnun, Monica P. ^{[4
]}

Saurit, Veronica ^{[5
]}

Cardiel, Mario H. ^{[6
]}

Soriano, Enrique R. ^{[7
]}

Pisoni, Cecilia ^{[8
]}

Galarza-Maldonado, Claudio M. ^{[9
]}

Rios, Carlos ^{[10
]}

Radominski, Sebastiao C. ^{[11
]}

Castelar-Pinheiro, Geraldo da R. ^{[12
]}

Bianchi, Washington Alves ^{[13
]}

Appenzeller, Simone ^{[14
]}

da Silveira, Ines Guimaraes ^{[15
]}

de Freitas Zerbini, Cristiano A. ^{[16
]}

Caballero-Uribe, Carlo V. ^{[17
]}

Rojas-Villarraga, Adriana ^{[18
]}

Guibert-Toledano, Marlene ^{[19
]}

Ballesteros, Francisco ^{[20
]}

Montufar, Ruben ^{[21
]}

Vazquez-Mellado, Janitzia ^{[22
]}

Esquivel-Valerio, Jorge ^{[23
]}

De La Torre, Ignacio Garcia ^{[24
]}

Barile-Fabris, Leonor A. ^{[25
]}

Palezuelos, Fedra Irazoque ^{[26
]}

Andrade-Ortega, Lilia ^{[26
]}

Monge, Pablo ^{[27
]}

Teijeiro, Raquel ^{[28
]}

Achurra-Castillo, Angel F. ^{[29
]}

Esteva Spinetti, Maria H. ^{[30
]}

Alarcon, Graciela S. ^{[31
]}

Pons-Estel, Bernardo A. ^{[4
,32
]}

机构：

[1] Hosp Nacl Guillermo Almenara Irigoyen, EsSalud, Serv Reumatol, Ave Miguel Grau 800, Lima 15033, Peru

[2] Univ Cient Sur, Lima, Peru

[3] Univ San Sebastian, Fac Med & Ciencia, Ctr Biol Celular & Biomed CEBICEM, Santiago, Chile

[4] Hosp Prov Rosario, Serv Reumatol, Rosario, Santa Fe, Argentina

[5] Hosp Privado Univ Cordoba, Serv Reumatol, Cordoba, Argentina

[6] Ctr Invest Clin Morelia, Morelia, Michoacan, Mexico

[7] Hosp Italiano Buenos Aires, Serv Clin Med, Secc Reumatol, Buenos Aires, DF, Argentina

[8] Ctr Educ Med Invest Clin Norberto Quirno CEMIC, Secc Inmunol & Reumatol, Buenos Aires, DF, Argentina

[9] Corp Med Monte Sinai, Unidad Enfermedades Reumat & Autoinmunes UNERA, Cuenca, Ecuador

[10] Univ Espiritu Santo, Ctr Reumatol & Rehabil, Guayaquil, Ecuador

[11] Univ Fed Parana, Hosp Clin, Serv Reumatol, Curitiba, Parana, Brazil

[12] Univ Estado Rio de Janeiro, Dept Med Interna, Disciplina Reumatol, Rio De Janeiro, Brazil

[13] Univ Estado Rio de Janeiro, Fac Ciencias Med, Dept Med Interna,Fac Med,Univ Estacio Sa, Serv Reumatol,Hosp Gen Santa Casa Misericordia Ri, Rio De Janeiro, Brazil

[14] Univ Estadual Campinas, Rheumatol Unit, Sch Med Sci, Campinas, SP, Brazil

[15] Pontificia Univ Catolica Rio Grande do Sul, Porto Alegre, RS, Brazil

[16] Ctr Paulista Invest Clin, Sao Paulo, Brazil

[17] Hosp Univ Norte, Serv Reumatol, Barranquilla, Colombia

[18] Fdn Univ Ciencias Salud FUCS, Bogota, Colombia

[19] Hosp Clin Quirurg Diez de Octubre, Serv Reumatol, Havana, Cuba

[20] Hosp Clin San Borja Arriaran, Serv Reumatol, Santiago, Chile

[21] Consultorio Especialidades Inst Salvadoreno Segur, Dept Reumatol, San Salvador, El Salvador

[22] Hosp Gen Mexico City, Serv Reumatol, Mexico City, DF, Mexico

[23] Hosp Univ Dr Jose Eleuterio Gonzalez, Serv Reumatol, Monterrey, Mexico

[24] Univ Guadalajara, Hosp Gen Occidente, Dept Inmunol & Reumatol, Guadalajara, Jalisco, Mexico

[25] Hosp Angeles Pedregal, Serv Reumatol, Mexico City, DF, Mexico

[26] Cto Med Nacl 20 Noviembre, Serv Reumatol, Mexico City, DF, Mexico

[27] Univ Costa Rica, HospitalMexico, Caja Costarricense Seguro Social, San Jose, Costa Rica

[28] MUCAM, Montevideo, Uruguay

[29] Complejo Hosp Metropolitano Dr Arnulfo Arias Madr, Caja Seguro Social Panama, Panama City, Panama

[30] Hosp Cent San Cristobal, Dept Med, Serv Reumatol, San Cristobal, Venezuela

[31] Univ Alabama Birmingham, Sch Med, Dept Med, Div Clin Immunol & Rheumatol, Birmingham, AL USA

[32] Ctr Reg Enfermedades Autoinmunes & Reumat CREAR, Dept Med Interna, Grp Orono, Rosario, Santa Fe, Argentina

来源：

CLINICAL RHEUMATOLOGY | 2019年 / 38卷 / 10期

关键词：

Early RA outcomes; Early RA remission; Early RA response predictors; Latin America early RA;

D O I：

10.1007/s10067-019-04742-8

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Objectives: To identify baseline predictors of remission and low disease activity (LDA) in early rheumatoid arthritis (RA) from the GLADAR (Grupo Latino Americano De estudio de la Artritis Reumatoide) cohort. Methods: Patients with 1- and 2-year follow-up visits were included. Remission and LDA were defined by DAS28-ESR (< 2.6 and ≤ 3.2, respectively). Baseline predictors examined were gender, ethnicity, age at diagnosis, socioeconomic status, symptoms’ duration, DMARDs, RF, thrombocytosis, anemia, morning stiffness, DAS28-ESR (and its components), HAQ-DI, DMARDs and corticosteroid use, and Sharp-VDH score. Multivariable binary logistic regression models (excluding DAS28-ESR components to avoid over adjustment) were derived using a backward selection method (α-level set at 0.05). Results: Four hundred ninety-eight patients were included. Remission and LDA/remission were met by 19.3% and 32.5% at the 1-year visit, respectively. For the 280 patients followed for 2 years, these outcomes were met by 24.3% and 38.9%, respectively. Predictors of remission at 1 year were a lower DAS28-ESR (OR 1.17; CI 1.07–1.27; p = 0.001) and HAQ-DI (OR 1.48; CI 1.04–2.10; p = 0.028). At 2 years, only DAS28-ESR (OR 1.40; CI 1.17–1.6; p < 0.001) was a predictor. Predictors of LDA/remission at 1 year were DAS28-ESR (OR 1.42; CI 1.26–1.61; p < 0.001), non-use of corticosteroid (OR 1.74; CI 1.11–2.44; p = 0.008), and male gender (OR 1.77; CI 1.2–2.63; p = 0.036). A lower baseline DAS28-ESR (OR 1.45; CI 1.23–1.70; p < 0.001) was the only predictor of LDA/remission at 2 years. Conclusions: A lower disease activity consistently predicted remission and LDA/remission at 1 and 2 years of follow-up in early RA patients from the GLADAR cohort.Key Points• In patients with early RA, a lower disease activity at first visit is a strong clinical predictor of achieving remission and LDA subsequently.• Other clinical predictors of remission and LDA to keep in mind in these patients are male gender, non-use of corticosteroids and low disability at baseline.• Not using corticosteroids at first visit is associated with a lower disease activity and predicts LDA/remission at 1 year in these patients. © 2019, International League of Associations for Rheumatology (ILAR).

引用

页码：2963 / 2964

页数：2

共 50 条

[41] THE IMPACT OF NUMBER OF COMORBIDITIES ON ACHIEVEMENT REMISSION OR LOW DISEASE ACTIVITY BY DAPSA IN PSORIATIC ARTHRITIS. DATA FROM THE RUSSIAN OBSERVATIONAL COHORT
Korsakova, Y.
Gubar, E.
Loginova, E.
Korotaeva, T.
Sorotskaya, V.
Patrikeeva, I.
Shesternya, P.
Umnova, I.
Nasonov, E.
ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 871 - 872
[42] Patients with longstanding psoriatic arthritis can achieve DAPSA remission or low disease activity and it correlates to better functional outcomes: results from a Latin-American real-life cohort
Larissa Vargas Cruz
Júlia Boechat Farani
Júlia Rabello Costa
João Victor de Andrade Águas
Bruna Ruschel
Franciele de Almeida Menegat
Andrese Aline Gasparin
Claiton Viegas Brenol
Charles Lubianca Kohem
Adrieli Bessa
Francisco Forestiero
Felipe Thies
Penélope Esther Palominos
Advances in Rheumatology, 64
[43] CLINICAL, FUNCTIONAL, AND STRUCTURAL CONSEQUENCES OF TARGETING LOW DISEASE ACTIVITY RATHER THAN REMISSION IN EARLY AND ESTABLISHED RHEUMATOID ARTHRITIS USING METHOTREXATE OR METHOTREXATE PLUS ADALIMUMAB
Aletaha, D.
Keystone, E.
Kupper, H.
Liu, S.
Florentinus, S.
van Vollenhoven, R. F.
ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 930 - 930
[44] Aiming Simple Disease Activity Score Remission At One Year Leads To Better 3-Year Radiographic and Functional Outcomes Than aiming low Disease activity in Early Rheumatoid Arthritis Patients Treated In Routine Practice. Data From Espoir Cohort
Ruyssen-Witrand, Adeline
Guernec, Gregory
Nigon, Delphine
Tobon, Gabriel
Jamard, Benedicte
Rat, Anne-Christine
Vittecoq, Olivier
Cantagrel, Alain G.
Constantin, Arnaud L.
ARTHRITIS AND RHEUMATISM, 2013, 65 : S554 - S555
[45] The Role Of Patient Global Disease Activity Score In The Definition Of American College Of Rheumatology/European League Against Rheumatism Remission In Very Early Rheumatoid Arthritis From The Norwegian Very Early Arthritis Clinic.
Mjaavatten, Maria Dahl
Haugen, Anne Julsrud
Nygaard, Halvor
Bjorneboe, Olav
Stolt, Patrik
Thunem, Cathrine
Kvien, Tore Kristian
ARTHRITIS AND RHEUMATISM, 2013, 65 : S977 - S977
[46] If remission and low disease activity is the treatment goal in rheumatoid arthritis, how far are we from this goal in patients currently treated with biologics in ordinary clinical practice? Data from the Norwegian BIORHEUMA project
Haugeberg, G.
Bader, L.
Hoff, M.
Haaland, K.
Gjesdal, C.
Storesund, B.
Gulseth, H. C.
Haavardsholm, E.
Mikkelsen, K.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2012, 41 : 58 - 58
[47] IN EARLY RHEUMATOID ARTHRITIS (RA) PATIENTS PERSISTENT MODERATE DISEASE ACTIVITY DURING THE FIRST YEAR HAS A WORST 3 AND 5 YEAR OUTCOME THAN THOSE IN REMISSION : DATA FROM THE ESPOIR COHORT
Combe, B.
Logeart, I.
Belkacemi, M.
Schaeverbeke, T.
Daures, J. -P.
Dougados, M.
ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 205 - 205
[48] Patients with longstanding pPatients with longstanding psoriatic arthritis can achieve DAPSA remission or low disease activity and it correlates to better functional outcomes: results from a Latin-American real-life cohort
Cruz, Larissa Vargas
Farani, Julia Boechat
Costa, Julia Rabello
Aaguas, Joao Victor de Andrade
Ruschel, Bruna
Menegat, Franciele de Almeida
Gasparin, Andrese Aline
Brenol, Claiton Viegas
Kohem, Charles Lubianca
Bessa, Adrieli
Forestiero, Francisco
Thies, Felipe
Palominos, Penelope Esther
ADVANCES IN RHEUMATOLOGY, 2024, 64 (01)
[49] What role do socioeconomic and clinical factors play in disease activity states in rheumatoid arthritis? Data from a large UK early inflammatory arthritis audit
Adas, Maryam
Dey, Mrinalini
Norton, Sam
Lempp, Heidi
Buch, Maya H.
Cope, Andrew
Galloway, James
Nikiphorou, Elena
RMD OPEN, 2024, 10 (03):
[50] Comparison of the long-term outcome for patients with rheumatoid arthritis with persistent moderate disease activity or disease remission during the first year after diagnosis: data from the ESPOIR cohort
Combe, B.
Logeart, I.
Belkacemi, M. C.
Dadoun, S.
Schaeverbeke, T.
Daures, J. P.
Dougados, M.
ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (04) : 724 - 729

← 1 2 3 4 5 →